+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 1
Age: 18Years - 50Years
All Genders
Healthy Volunteers
ID07111078

Evaluation of a Quadrivalent Influenza HA Stem Vaccine SteMos1 With and Without ALFQ Adjuvant in Healthy Adults for Flu Prevention

Led by National Institute of Allergy and Infectious Diseases (NIAID) · Updated on 2026-10-20

56

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating a new quadrivalent influenza HA stem vaccine called VRC-FLUMOS0122-00-VP SteMos1 with and without the ALFQ adjuvant in healthy adults aged 18 to 50. The study aims to assess the safety, tolerability, and immune response of this vaccine and to determine if adding the ALFQ adjuvant enhances immune responses. This phase I, open-label, dose escalation trial involves multiple groups receiving different doses and combinations of the vaccine and adjuvant. Participants receive two doses of the SteMos1 vaccine, either alone or combined with 0.5 ml of ALFQ adjuvant, administered by injection into the upper arm muscle on Day 0 and Week 16. Groups include varying doses of 60 mcg or 180 mcg of the vaccine with or without the adjuvant, and a fifth optional group with a dose chosen based on interim safety data. The trial includes detailed safety reviews after initial participants in each group to guide enrollment progression. During the 68-week study period, participants attend 12 clinic visits and 4 phone calls for monitoring through the influenza season. After each vaccination, participants are observed for 30 minutes and keep a 7-day diary of symptoms and temperature. Blood and mucosal samples are collected regularly to assess immune responses, and participants may opt for apheresis to collect white blood cells. Safety assessments include clinical exams and lab tests to monitor health changes and vaccine effects.

CONDITIONS

Brief Title

Quadrivalent Influenza HA Stem Vaccine VRC-FLUMOS0122-00-VP (SteMos1) With and Without ALFQ Adjuvant in Healthy Adults

Research Team

V

VRC Clinic

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here